Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
Thrombosis and Haemostasis|November 15, 2013
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
The New England Journal of Medicine|December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIC Michael Gibson, Roxana Mehran, Christoph Bode, et al.
Clinical Chemistry|December 3, 2014
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
Thrombosis and Haemostasis|March 1, 2013
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
European Heart Journal|May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomesChristoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
Circulation|May 11, 2012
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attackStefan K James, Robert F Storey, Nardev S Khurmi, et al.
Journal of the American College of Cardiology|April 14, 2012
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paperRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Circulation|March 3, 2010
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND studyPaul A Gurbel, Kevin P Bliden, Kathleen Butler, et al.
Pageof 10